Gossamer Bio (GOSS) Price-to-Earnings (P/E) Ratio
Price: $0.9766
Market Cap: $221.90M
Avg Volume: 1.60M
Market Cap: $221.90M
Avg Volume: 1.60M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Gossamer Bio's P/E ratios across different time periods:
- TTM: -3.91
- Annual: -3.62
- Quarterly: -1.55
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 6.94
- Price-to-Sales (P/S) Ratio: 1.78
Annual Ratios
Gossamer Bio Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-3.91
P/B Ratio (Annual)
6.94
P/S Ratio (Annual)
1.78
Gossamer Bio Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -3.62 | 6.94 | 1.78 |
| 2023 | -0.77 | 2.22 | 0.00 |
| 2022 | -0.76 | -0.18 | 0.00 |
| 2021 | -3.40 | -1.04 | 0.00 |
| 2020 | -2.63 | -1.15 | 0.00 |
| 2019 | -4.73 | -2.56 | 0.00 |
| 2018 | -7.37 | -9.02 | 0.00 |
| 2017 | -65.79 | -64.92 | 0.00 |
| 2016 | -5367.15 | -3621.74 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for GOSS.